PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Paradigm to go for Provisional Approval on the basis of durability of effect, which is something not seen with current pain medications.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.